Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000157824 | SCV000207754 | pathogenic | not provided | 2013-12-05 | criteria provided, single submitter | clinical testing | p.Phe595Leu (TTT>TTA): c.1785 T>A in exon 15 of the BRAF gene (NM_004333.4). The F595L missense mutation resulting from nucleotide substitutions c.1785 T>A and c.1785 T>G in the BRAF gene has been reported in association with cardio-facio-cutaneous syndrome (Schulz et al., 2008 and Rodriguez-Viciana et al., 2006). This amino acid substitution occurs at a highly conserved residue of the protein. Many other missense mutations (N580D, N581D, G596V, L597V, T599A) have been reported in surrounding residues. The F595L mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant is found in NOONAN panel(s). |
Invitae | RCV001212304 | SCV001383884 | pathogenic | RASopathy | 2021-07-13 | criteria provided, single submitter | clinical testing | |
Database of Curated Mutations |
RCV000437147 | SCV000505588 | likely pathogenic | Melanoma | 2015-07-14 | no assertion criteria provided | literature only |